! " #$% &' ()* + ",- /. 0 +12 3 *465789:; / <=>42010? @AB C©6DDDDEEEEFFFFGGGGHHHHIIIIKJJJJ6LLLLMMMMNNNNOOOOPPPPQQQQKRRRR6SSSSTTTTUUUUVVVVWWWWXXXXYYYYZZZZ[[[[\\\\^]]]]/____EEEE````aaaabbbbccccddddeeeeffffgggg4hhhh]]]] ikjmlonkpmqortsvuxwypmqkr{z}|~ot wnk{z12o29.00mmkv m¡£¢¤¦¥o§m ̈ © ª «£¢v¬o®m ̄t°s²± ³μ ́·¶m ̧q ̄¹kºm»k¼½¦¾À¿mÁvÂoÃkÄ¢ikjoÅ Æ®v ̄oÇkÈ ÉvÊ£ 2009Ë11¢°mskÌÀÍkÎoÏÐmÑËoÒoÓ2%ÐÔvÕvÖo×oØ̲٣ÚvÛ ́ÆÜÌÝÞ~ ßmàkáâ¢2009Ë11¦ Ñ o¡3%¢ÑË k¡6%¦ã·ä09Ë åmækËçtètéäê{ë¢ ìtíî «t¬£å¢ ï{ðÌoñ{òÒ£ÓtóÆ£ôõ¢ÑËtÒ£ö16%Àv÷¢Ëoøoùkú¢1ù11ë¦û²üåký2% p qkrÖkþÿ À¿ÍoÎmÏ k ÉwQQUCTzwã òz£¢imj ŦƽÓëmÃmÄé !"t¢p qmr#$ %è£Ì&ÍoÎoÏ')(*+¥oÉ ¢,QQUCT#ì-kÃ.Ë/Ʀ¥kÉ)012'(43#65éá67è¥)89:;<=¢>Æ®?¥@ÙopqmrA °ç èÖBm§£¢)CmüD äEFGHIm÷¥oɦ¢p qmr#Jÿ¾áòKL5éÌM¢ONO@POQRSTt U2009Ë5VÚÃí¢°sOW6XY6Z[\6]^6(ä503]`_a``b6cÚed>f¢imj ŦƢμ ́·¶m ̧qüÙg6hi)jtÌekl`mnopqT§{4rstf¢pqoroŦƢ£ã·ä6uOvdwx{Ú47y¢>fì2009˱z`{ûÚ2010Ë¢Î|uw~}OËÿ)"zü#mn 2010111 / ) ¡£¢¤¥§¦© ̈ª©«¬®/ "#$ ̄±°²³«¬ ́μ¶· ̧ ́μ¶· ̧ ́μ¶· ̧ ́μ¶· ̧) ¡£¢¤¥§¦© ̈ª©«¬®/ "#$ ̄±°²³«¬ ¹º»¼½¾À¿±Á£Â>ÄÃŤ²³«¬ÄÆÈÇÉÊËÌÊ5%ÍÈÎÏ 52ÐÑÒÓÔÖÕØ×ÙeÚ 12.20 - 29.80 ÛÜÝ 63,473 ÑÞßàáÕãâäÑeÚ 2,423 åÄæçèéÕ'000Ú 6,339 êìëîí/ÑìïðîñòÕ%Ú 19.1 2009óôõÑö4÷ùøúòÕ%Ú 8.7 ûüûüûüûü12ýîþÿ ýîþÿ ýîþÿ ýîþÿ 2008 2009¶·¶·¶·¶· 2010¶·¶·¶·¶· 2011¶·¶·¶·¶· (%) 4,135 3,712 4,097 4,597 3.6 EBITDA 2,791 1,830 2,179 2,439 -4.4 ø 4,014 3,143 3,624 4,132 1.0 ø 3,706 2,699 3,125 3,569 -1.2 ø Ñ!ÕØ×ÙÚ 1.53 1.11 1.29 1.47 -1.2 Ü!úòÕ#"eÚ 17.1 23.5 20.3 17.8 - ÑÑ$ÕØ×ÙÚ 0.68 0.49 0.57 0.65 -1.6 Ñ$ú(%) 2.6 1.9 2.2 2.5 - % &' ()ð * 144 HK +,- 0144.HK ./021 34 56 789:;526 BBB 12<=)à.Ò >Ò ôõ12<2=Û÷øÕ%Ú 10.7 Kah Ling Chan ?@ABC 65-6438 2881 kahling_chan@standardandpoors.com 29 26 D×2EFG 2 Standard & Poor’s Equity Research 2010ó1=11å HIJLK2HIJLK2HIJLK2HIJLK2 ¤¥o§mêNMÛ ́£îv«£¢>f°s ́¶m ̧q ̄]NOd«{eMÆvñ6bQPNR§£¢pmqkr2010˼QSvLT¼QUvQVmÆ20.3WT1.9W¢YXkä[Z2\m ̄¦¢^]L_Q`ba±ìñ/ÌÐÜdcoá(¢imjmÅÆZfde¢v®m ̄gf4vihLjäNkmëÌë°Èt¢ÉkÊá )mlk¾À¿Ì¼LnGbo iojtÌo29.00mmno¢®kÈÙNpqZ\ ̄oÇoÈÚÖbrkþÌYsQtQu°wvixÂmyw6°wvμzw1199 HK¢2gzb{+μz Ìw|Mi}i~ÛijM+2010ËêLM ̄SÌ21.3W¼QSvLQÈÌ1.7W¼QUv¦¢eö ̄k ̄N0.57mÇoÈb\oÙQ ]LN &QZ\ ̄ÌÇmÈÚ£°^v2010˼Sv|40%T¼QUv|20%¦dLQ|Ù 2003Ë3.£û²Éww»ñòÚÃÌdç èMb}Y äpqmr{ÌQRwѼÈNMN}t¢mf°Yv»1.5Wz¢ikjkÅÆOZLb±Q| ¤¦¥1"ÌYbq>sYNbêëbd¢w §°sÿ±ÜQ`mn b¡Q¢Pmn£w¤¢¥b¦°msvÛ ́Ì k¡§ ävêmë 3 Standard & Poor’s Equity Research 2010ó1=11å HIJLK2HIJLK2HIJLK2HIJLK2 ̈ © ̧ ̈ © ̧ ̈ © ̧ ̈ © ̧ ¡£¢¤¥§¦© ̈ª©«¬®/ "#$ ̄±°²³«¬ ûüûüûüûü12ýîþÿ ýîþÿ ýîþÿ ýîþÿ O 2007 2008 2009¶·¶·¶·¶· 2010¶·¶·¶·¶· 2011¶·¶·¶·¶· 3,345 4,135 3,712 4,097 4,597 EBITDA 2,129 2,791 1,830 2,179 2,439 ªY«¬® -626 -758 -798 -848 -898 EBIT 3,613 4,014 3,143 3,624 4,132 ê ̄G°²±òÕ ́³;Ú -535 -276 -112 -136 -230 μ2¶· 2,705 2,663 2,621 2,858 3,283 ø 3,613 4,014 3,143 3,624 4,132 ̧¹ -174 -220 -157 -181 -207 º»úÕ%Ú 4.8 5.5 5.0 5.0 5.0 ¼ßÑìï -350 -320 -287 -317 -356 ø 3,545 3,706 2,699 3,125 3,569 2,838 2,564 2,699 3,125 3,569 Õ%Ú -15.6 23.6 -10.2 10.4 12.2 EBITDAÕ%Ú 103.1 31.1 -34.4 19.1 11.9 EBITÕ%Ú 31.7 11.1 -21.7 15.3 14.0 òÕ%Ú 29.2 -9.7 5.3 15.8 14.2 ½¾ ½¾ ½¾ ½¾ EBITDAúÕ%Ú 63.6 67.5 49.3 53.2 53.0 EBITúòÕ%Ú 108.0 97.1 84.7 88.4 89.9 úòÕ%Ú 84.8 62.0 72.7 76.3 77.6 4 Standard & Poor’s Equity Research 2010ó1=11å HIJLK2HIJLK2HIJLK2HIJLK2 ¿ À2Á²Â ̧¿ À2Á²Â ̧¿ À2Á²Â ̧¿ À2Á²Â ̧ ¢¤¥Ä¦£ ̈ª£«¬Ä6 " #$£ ̄®°£²³«¬ ÃÄÅYÆ ÃÄÅYÆ ÃÄÅYÆ ÃÄÅYÆ ¡Å¢©¤©¥±¦Å ̈©ªÅ«©¬ /"/#$6/È ̄°È²©³©«©¬ ûüûüûüûü12ýîþÿ ýîþÿ ýîþÿ ýîþÿ O 2007 2008 2009¶·¶·¶·¶· 2010¶·¶·¶·¶· 2011¶·¶